275 related articles for article (PubMed ID: 19774788)
1. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
Leclerc E; Sturchler E; Vetter SW; Heizmann CW
Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
[TBL] [Abstract][Full Text] [Related]
2. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
3. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.
Chen X; Walker DG; Schmidt AM; Arancio O; Lue LF; Yan SD
Curr Mol Med; 2007 Dec; 7(8):735-42. PubMed ID: 18331231
[TBL] [Abstract][Full Text] [Related]
4. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
5. RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?
Yan SD; Bierhaus A; Nawroth PP; Stern DM
J Alzheimers Dis; 2009; 16(4):833-43. PubMed ID: 19387116
[TBL] [Abstract][Full Text] [Related]
6. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
Yan SS; Chen D; Yan S; Guo L; Du H; Chen JX
Front Biosci (Schol Ed); 2012 Jan; 4(1):240-50. PubMed ID: 22202057
[TBL] [Abstract][Full Text] [Related]
7. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
8. The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine.
Leclerc E; Heizmann CW
Front Biosci (Schol Ed); 2011 Jun; 3(4):1232-62. PubMed ID: 21622268
[TBL] [Abstract][Full Text] [Related]
9. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY
Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.
Walker D; Lue LF; Paul G; Patel A; Sabbagh MN
Expert Opin Investig Drugs; 2015 Mar; 24(3):393-9. PubMed ID: 25586103
[TBL] [Abstract][Full Text] [Related]
11. The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells.
Du H; Li P; Wang J; Qing X; Li W
Cell Mol Neurobiol; 2012 Jan; 32(1):141-7. PubMed ID: 21837459
[TBL] [Abstract][Full Text] [Related]
12. Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.
Zhang L; Postina R; Wang Y
Cell Mol Life Sci; 2009 Dec; 66(24):3923-35. PubMed ID: 19672558
[TBL] [Abstract][Full Text] [Related]
13. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
[TBL] [Abstract][Full Text] [Related]
14. Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.
Yan SD; Roher A; Chaney M; Zlokovic B; Schmidt AM; Stern D
Biochim Biophys Acta; 2000 Jul; 1502(1):145-57. PubMed ID: 10899440
[TBL] [Abstract][Full Text] [Related]
15. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
[TBL] [Abstract][Full Text] [Related]
16. Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
Carnevale D; Mascio G; D'Andrea I; Fardella V; Bell RD; Branchi I; Pallante F; Zlokovic B; Yan SS; Lembo G
Hypertension; 2012 Jul; 60(1):188-97. PubMed ID: 22615109
[TBL] [Abstract][Full Text] [Related]
17. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
18. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
19. RAGE: the beneficial and deleterious effects by diverse mechanisms of actions.
Han SH; Kim YH; Mook-Jung I
Mol Cells; 2011 Feb; 31(2):91-7. PubMed ID: 21347704
[TBL] [Abstract][Full Text] [Related]
20. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
